On January 22, Bailong Chuangyuan Co., Ltd. (stock code: 605016) released its preliminary financial results for the fiscal year 2025, revealing a robust performance marked by strong revenue growth and significant improvements in profitability. The announcement underscores the company’s steady expansion momentum, enhanced operational efficiency, and growing competitiveness within the functional food ingredients and bio-manufacturing sectors.
According to the disclosed data, Bailong Chuangyuan achieved operating revenue of RMB 1.379 billion in 2025, representing a year-on-year increase of 19.75%. This solid top-line growth reflects the company’s continued success in expanding its core product portfolio, strengthening downstream customer relationships, and capturing rising demand for health-oriented food ingredients both in domestic and international markets. Against a backdrop of intensifying competition and fluctuating macroeconomic conditions, the nearly 20% revenue growth highlights the company’s strong market positioning and resilient business model.
Operating profit for the year reached RMB 432 million, surging 51.59% compared with the previous year. Total profit amounted to RMB 432 million as well, up 51.29% year-on-year. The faster growth rate of profits relative to revenue indicates a notable improvement in profitability, driven by optimized product mix, cost control initiatives, and economies of scale. In particular, the company has continued to focus on high value-added functional sugar products, which typically offer higher gross margins than traditional products, thereby lifting overall earnings quality.
Net profit attributable to shareholders of the listed company totaled RMB 366 million, representing a substantial year-on-year increase of 48.94%. This impressive bottom-line performance further demonstrates the effectiveness of the company’s strategic initiatives and operational execution. The growth in net profit not only reflects higher operating income but also suggests disciplined expense management and stable financial structure, which together contributed to enhanced returns for shareholders.
From a business perspective, Bailong Chuangyuan has benefited from sustained demand growth in the functional food, nutrition, and health-related industries. As consumer awareness of health, dietary fiber, and gut health continues to rise, demand for products such as galacto-oligosaccharides (GOS), dietary fibers, and other functional carbohydrates has remained strong. The company’s long-term focus on research and development has enabled it to continuously improve product quality and diversify applications, allowing it to better meet evolving customer needs across food, beverage, dairy, and nutritional supplement sectors.
In addition, the company’s ongoing capacity expansion and technological upgrades have played a key role in supporting revenue and profit growth. By improving production efficiency and stabilizing product quality, Bailong Chuangyuan has been able to reduce unit costs while ensuring consistent supply to major clients. These operational improvements have translated into higher margins and enhanced competitiveness, particularly in export markets where quality standards and supply reliability are critical.
The significant increase in operating profit also reflects the company’s strengthened cost management capabilities. Through refined procurement strategies, optimized energy utilization, and streamlined internal processes, Bailong Chuangyuan has effectively mitigated the impact of raw material price fluctuations and other cost pressures. This ability to balance growth with cost discipline has become an important driver of the company’s earnings resilience.
From a financial standpoint, the preliminary results suggest that Bailong Chuangyuan is entering a new stage of high-quality growth. The company has successfully transitioned from a phase of scale expansion to one that emphasizes profitability, efficiency, and sustainable development. The sharp rise in profit indicators relative to revenue growth points to improving operating leverage, which could provide further upside as capacity utilization continues to increase.
Looking ahead, management has indicated that the company will continue to invest in innovation and market development. Research and development remain a strategic priority, particularly in areas such as functional sugars, prebiotics, and specialty dietary fibers. These segments not only align with long-term consumption trends but also offer higher technical barriers and profit margins, supporting the company’s long-term value creation.
Moreover, Bailong Chuangyuan is expected to further expand its presence in overseas markets. With increasing global demand for clean-label, health-oriented ingredients, the company is well positioned to leverage its technological expertise and cost advantages to deepen cooperation with international clients. Export growth could become an important incremental driver of revenue and profit in the coming years.
From the capital market’s perspective, the strong preliminary results for 2025 may enhance investor confidence in the company’s growth trajectory and earnings sustainability. The nearly 50% growth in net profit attributable to shareholders highlights the company’s ability to deliver tangible value to investors, while the solid revenue expansion provides visibility into future growth potential.
In conclusion, Bailong Chuangyuan’s preliminary 2025 annual results demonstrate a year of outstanding performance, characterized by robust revenue growth, sharply rising profits, and improved operating efficiency. As the company continues to capitalize on favorable industry trends, strengthen its core competencies, and execute its long-term strategy, it is well positioned to maintain stable growth and further enhance its competitive edge in the functional food ingredients industry.
